Single-cell Omics Market to Grow at a CAGR of 6.87% through 2029F
Growing
biotechnology & biopharmaceutical industries and advances in single-cell
technologies is expected to drive the Global Single-cell Omics Market growth in
the forecast period, 2025-2029.
According
to TechSci Research report, “Single-cell Omics Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the
Global Single-cell Omics Market stood at USD 1.42 billion in 2023 and is
anticipated to reach USD 2.10 Billion by 2029 with a CAGR of 6.87% during the
forecast period. The
adoption of artificial intelligence (AI) in single-cell omics analysis is
reshaping the landscape, enabling researchers to derive deeper insights from
vast datasets. AI-powered algorithms streamline the interpretation of complex
data generated from single-cell technologies by identifying patterns,
classifying cell types, and predicting cell behavior. These advancements
significantly reduce the time and cost required for data analysis while
improving the accuracy of results. For instance, AI tools facilitate the
development of predictive models that aid in understanding disease progression
at a single-cell level, offering potential applications in precision medicine.
Machine learning models are being utilized to enhance the robustness of
single-cell sequencing by correcting errors and imputing missing data, which
are common challenges in high-throughput studies. This integration allows for
better standardization and reproducibility of results across different research
centers. As the global single-cell omics market continues to expand, the
incorporation of AI will likely become a critical differentiator for companies
aiming to deliver advanced analytical solutions. AI-enabled platforms
are also enhancing cross-disciplinary applications, such as integrating
multi-omics data for comprehensive cellular profiling. This trend is driving
partnerships between tech companies and biotechnology firms, further accelerating
innovation. The growing interest in AI-based single-cell omics solutions
underscores its transformative potential to optimize research, particularly in
drug discovery, personalized medicine, and cancer therapeutics.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Single-cell Omics Market”
Spatial
transcriptomics is emerging as a groundbreaking trend in the single-cell omics
market, offering researchers the ability to map gene expression within the
spatial context of tissues. This technology bridges the gap between genomics
and histology, allowing scientists to visualize cellular heterogeneity while
preserving spatial information. Unlike traditional single-cell methods that
dissociate cells, spatial transcriptomics maintains the tissue's architecture,
providing valuable insights into cellular interactions and microenvironmental
influences. The increasing adoption of spatial transcriptomics is fueled by
advancements in imaging and sequencing technologies, which have enhanced
resolution and throughput. This trend has unlocked new opportunities in
understanding developmental biology, neuroscience, and oncology, where spatial
context is critical to unraveling complex cellular dynamics. Researchers are
now leveraging this technology to study tumor microenvironments, revealing
critical insights into cancer progression and therapeutic resistance.
Companies
are also investing in the development of user-friendly spatial transcriptomics
platforms, making the technology accessible to a broader range of laboratories.
For example, collaborations between biotechnology firms and academic
institutions are accelerating the commercialization of spatial transcriptomics
solutions, facilitating their integration into clinical workflows.
The
Global Single-cell Omics Market is segmented into product type, application,
end user, regional distribution, and company.
Based on end user, pharmaceutical and
biotechnology companies are currently dominating the Global Single-cell Omics
Market. These companies are at the forefront of adopting single-cell
technologies due to their critical role in drug discovery, precision medicine,
and therapeutic development. The ability to analyze individual cells at a
genomic, transcriptomic, or proteomic level enables these organizations to gain
insights into cellular heterogeneity, disease mechanisms, and therapeutic
responses. As a result, pharmaceutical and biotechnology companies are
leveraging single-cell omics to identify novel drug targets, optimize clinical
trials, and enhance personalized treatment strategies, particularly in areas
like cancer, immunology, and neurology. The pharmaceutical sector’s
investment in single-cell technologies is propelled by the increasing demand
for targeted therapies and the need for more accurate patient stratification.
With a growing emphasis on precision medicine, these companies are continuously
seeking to integrate advanced single-cell analysis into their R&D
pipelines, further solidifying their dominance in the market.
After
North America, Europe is the second dominating region in the Global Single-cell
Omics Market. The region benefits from a strong presence of leading academic
and research institutions, as well as major pharmaceutical and biotechnology
companies, driving the adoption of single-cell omics technologies. European
countries, particularly Germany, the United Kingdom, and France, are heavily
invested in advancing genomics, precision medicine, and cancer research, all of
which benefit from the insights provided by single-cell analysis.
Europe
also benefits from favorable regulatory environments and substantial funding
for scientific research, which further accelerates the growth of the
single-cell omics market. Collaborative initiatives between universities,
research organizations, and private companies have fostered an ecosystem
conducive to innovation in single-cell technologies. The
increasing emphasis on personalized medicine in Europe is encouraging the
integration of single-cell omics into clinical practices, particularly in
oncology and immunology. With the rise of multi-omics and precision medicine
initiatives, the demand for single-cell technologies is expected to grow even
further in Europe, maintaining its position as a significant player in the
global market.
Major
companies operating in Global Single-cell Omics Market are:
- Danaher Corporation
- CYTENA GmbH
- 10x Genomics Inc
- Becton, Dickinson and Company
- Cellenion SASU
- PerkinElmer Inc.
- ANGLE plc
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Mission Bio, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“The
single-cell omics market is witnessing a growing emphasis on multi-omics
approaches, which integrate various omics layers—such as genomics,
transcriptomics, proteomics, and metabolomics—at the single-cell level. This
holistic strategy provides a comprehensive understanding of cellular function
and heterogeneity, surpassing the limitations of single-omics studies. The
trend toward multi-omics integration is driven by advancements in
high-throughput sequencing technologies and bioinformatics tools capable of
handling complex datasets. Researchers are increasingly adopting multi-omics to
investigate intricate biological systems, such as immune responses, cancer
evolution, and developmental processes. This approach allows for simultaneous
analysis of genetic, epigenetic, and metabolic profiles, providing a more
nuanced perspective on cellular mechanisms. Pharmaceutical companies are
leveraging multi-omics data to accelerate drug discovery and development. By
identifying unique cellular signatures, these approaches aid in uncovering
novel drug targets and predicting therapeutic responses.,” said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Single-cell
Omics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Product Type (Single-Cell Genomics, Single-Cell Transcriptomics,
Single-Cell Proteomics, Single-Cell Metabolomics), By Application (Oncology,
Cell Biology, Neurology, Immunology), By End-User (Pharmaceutical &
Biotechnology Companies, Academic and Research Organizations, Hospital and
Diagnostic Laboratories, Others), By Region and Competition, 2019-2029F”, has
evaluated the future growth potential of Global Single-cell Omics Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Single-cell Omics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com